𝔖 Bobbio Scriptorium
✦   LIBER   ✦

THE INCIDENCE OF LEUKÆMIA IN ANKYLOSING SPONDYLITIS TREATED WITH X RAYS A PRELIMINARY REPORT

✍ Scribed by Brown, W.M.Court; Abbatt, JohnD.

Book ID
122540327
Publisher
The Lancet
Year
1955
Tongue
English
Weight
529 KB
Volume
265
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The incidence of leukemia and related di
The incidence of leukemia and related diseases in patients with rheumatoid (ankylosing) spondylitis treated with X-ray therapy
✍ Donald H. Silberberg; Lawrence A. Frohman; Ivan F. Duff 📂 Article 📅 1960 🏛 John Wiley and Sons 🌐 English ⚖ 779 KB

## Abstract In a series of 496 rheumatoid spondylitis patients treated with x‐ray, the authors have reported an incidence of leukemia over 17 times greater than expected in a comparable population. No conclusion can be drawn with respect to the exact nature of dose‐response relationship in leukemog

Validation exercise of the Ankylosing Sp
Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics
✍ Stone, Millicent A. ;Inman, Robert D. ;Wright, James G. ;Maetzel, Andreas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## Abstract ## Objectives To define what expert clinicians consider a dramatic response in ankylosing spondylitis (AS) patients treated with biologic therapies based on patient and physician assessments of global disease activity. To compare this expert clinician‐derived criteria to the Ankylosing

Decreased incidence of anterior uveitis
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept
✍ J. Braun; X. Baraliakos; J. Listing; J. Sieper 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Abstract ## Objective To estimate the incidence of anterior uveitis in patients with ankylosing spondylitis (AS) who underwent anti–tumor necrosis factor (anti‐TNF) therapy, using data from recently performed trials. ## Methods Data from 4 placebo‐controlled studies with anti‐TNF agents in AS